Current Drug Metabolism
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 2
Author(s): Albert P. Li
Affiliation:
Export Options
About this article
Cite this article as:
Li P. Albert, Meet Our Editorial Board Member, Current Drug Metabolism 2016; 17 (2) . https://dx.doi.org/10.2174/138920021702160114150829
DOI https://dx.doi.org/10.2174/138920021702160114150829 |
Print ISSN 1389-2002 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5453 |
23
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Endocannabinoid System: A Multi-Facet Therapeutic Target
Current Clinical Pharmacology Synthesis of Some New Hydroxytriazenes and their Antimicrobial and Anti-inflammatory Activities
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Regulation of Mitochondrial Biogenesis in Metabolic Syndrome
Current Drug Targets Role of TGF-β in Melanoma
Current Pharmaceutical Biotechnology Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects
Current Alzheimer Research Concepts for Biologically Active Peptides
Current Pharmaceutical Design Neurokinin Receptors and Subtypes as Potential Targets in Breast Cancer: Relevance to Bone Marrow Metastasis
Drug Design Reviews - Online (Discontinued) Controlled Delivery of Bioactive Molecules for the Treatment of Chronic Wounds
Current Pharmaceutical Design Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Current Pharmaceutical Design Are Oxidative Stress and Inflammation Mediators of Bone Loss Due to Estrogen Deficiency? A Review of Current Evidence
Endocrine, Metabolic & Immune Disorders - Drug Targets Fibrosis in the Anterior Segments of the Eye
Endocrine, Metabolic & Immune Disorders - Drug Targets A “Cute” Desensitization of TRPV1
Current Pharmaceutical Biotechnology Potential Role of Antibiotics in the Treatment of Asthma
Current Drug Targets - Inflammation & Allergy Phytochemicals for Drug Discovery in Alzheimer’s Disease: <i>In Silico</i> Advances
Current Pharmaceutical Design Old Drugs for New: Contemporary Immunosuppressant Development
Medicinal Chemistry Reviews - Online (Discontinued) Treatment of Insulin Resistance in the Neurodegeneration
Recent Patents on CNS Drug Discovery (Discontinued) The Comprehensive Appraisal of COVID-19: Its’ Clinical Panorama from Virology till Management and Beyond
Coronaviruses An Update on NLRP3 Inflammasome Activation by Engineered Nanomaterials
Current Bionanotechnology (Discontinued) New Insights into the Molecular Mechanisms of Corticosteroids Actions
Current Drug Targets Synthesis of Celecoxib and Structural Analogs- A Review
Current Organic Chemistry